High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles

1999-09-20

Human Reproduction , Volume 14 - Issue 9 p. 2242- 2244

Additional Metadata
Keywords	Ganirelix, GnRH antagonist, Ovarian stimulation, Pregnancy, Recombinant human FSH
Persistent URL	doi.org/10.1093/humrep/14.9.2242, hdl.handle.net/1765/64318
Journal	Human Reproduction
Organisation	Department of Gynaecology & Obstetrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kol, S, Lightman, A, Hillensjö, T, Devroey, P, Fauser, B.C.J.M, Tarlatzis, B.C, … Itskovitz-Eldor, J. (1999). High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Human Reproduction, 14(9), 2242–2244. doi:10.1093/humrep/14.9.2242

Publication